XML 177 R100.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity (Share-based Payments to Employees, Non-marketable Options, Grants Parameters) (Details)
 12 Months Ended
Dec. 31, 2023
USD ($)
yr
$ / shares
Granted 2016 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Share price (in $) | $ / shares $ 3.9
CPI-linked exercise price (in $) | $ $ 4.3
Fair value | $ $ 4,000,000
Weighted average grant date fair value per option (in $) | $ / shares $ 1.1
Granted 2017 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Share price (in $) | $ / shares $ 4.5
CPI-linked exercise price (in $) | $ $ 4.3
Fair value | $ $ 11,300,000
Weighted average grant date fair value per option (in $) | $ / shares $ 1.6
Granted 2018 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Share price (in $) | $ / shares $ 4.4
CPI-linked exercise price (in $) | $ $ 4.3
Fair value | $ $ 8,800,000
Weighted average grant date fair value per option (in $) | $ / shares $ 1.4
Granted 2019 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Share price (in $) | $ / shares $ 5.4
CPI-linked exercise price (in $) | $ $ 5.3
Fair value | $ $ 7,500,000
Weighted average grant date fair value per option (in $) | $ / shares $ 1.2
Granted 2021 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Share price (in $) | $ / shares $ 6.8
CPI-linked exercise price (in $) | $ $ 7.1
Fair value | $ $ 600,000
Weighted average grant date fair value per option (in $) | $ / shares $ 1.3
Granted 2022 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Share price (in $) | $ / shares $ 10
CPI-linked exercise price (in $) | $ $ 10.1
Fair value | $ $ 24,900,000
Weighted average grant date fair value per option (in $) | $ / shares $ 2
Granted 2023 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Share price (in $) | $ / shares $ 7.7
CPI-linked exercise price (in $) | $ $ 7.6
Fair value | $ $ 900,000
Weighted average grant date fair value per option (in $) | $ / shares $ 2
First tranche [Member] | Granted 2016 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 30.51%
Expected life of options (in years) 7
Equity Compensation Plan Risk Free Interest Rate 0.01%
First tranche [Member] | Granted 2017 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 31.88%
Expected life of options (in years) 7
Equity Compensation Plan Risk Free Interest Rate 0.37%
First tranche [Member] | Granted 2018 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 28.86%
Expected life of options (in years) 7
Equity Compensation Plan Risk Free Interest Rate 0.03%
First tranche [Member] | Granted 2019 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 27.85%
Expected life of options (in years) 4.4
Equity Compensation Plan Risk Free Interest Rate (0.67%)
First tranche [Member] | Granted 2021 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 31.70%
Expected life of options (in years) 4.4
Equity Compensation Plan Risk Free Interest Rate 0.43%
First tranche [Member] | Granted 2022 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 31.80%
Expected life of options (in years) 3.2
Equity Compensation Plan Risk Free Interest Rate (1.46%)
First tranche [Member] | Granted 2023 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 35.84%
Expected life of options (in years) 3.1
Equity Compensation Plan Risk Free Interest Rate 1.49%
Second tranche [Member] | Granted 2016 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 30.51%
Expected life of options (in years) 7
Equity Compensation Plan Risk Free Interest Rate 0.01%
Second tranche [Member] | Granted 2017 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 31.88%
Expected life of options (in years) 7
Equity Compensation Plan Risk Free Interest Rate 0.37%
Second tranche [Member] | Granted 2018 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 28.86%
Expected life of options (in years) 7
Equity Compensation Plan Risk Free Interest Rate 0.03%
Second tranche [Member] | Granted 2019 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 27.85%
Expected life of options (in years) 4.4
Equity Compensation Plan Risk Free Interest Rate (0.67%)
Second tranche [Member] | Granted 2021 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 31.70%
Expected life of options (in years) 4.4
Equity Compensation Plan Risk Free Interest Rate 0.43%
Second tranche [Member] | Granted 2022 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 30.88%
Expected life of options (in years) 3.8
Equity Compensation Plan Risk Free Interest Rate (1.29%)
Second tranche [Member] | Granted 2023 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 34.15%
Expected life of options (in years) 3.7
Equity Compensation Plan Risk Free Interest Rate 1.43%
Third tranche [Member] | Granted 2016 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 30.51%
Expected life of options (in years) 7
Equity Compensation Plan Risk Free Interest Rate 0.01%
Third tranche [Member] | Granted 2017 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 31.88%
Expected life of options (in years) 7
Equity Compensation Plan Risk Free Interest Rate 0.37%
Third tranche [Member] | Granted 2018 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 28.86%
Expected life of options (in years) 7
Equity Compensation Plan Risk Free Interest Rate 0.03%
Third tranche [Member] | Granted 2019 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 0.00%
Expected life of options (in years) 0
Equity Compensation Plan Risk Free Interest Rate 0.00%
Third tranche [Member] | Granted 2021 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 0.00%
Expected life of options (in years) 0
Equity Compensation Plan Risk Free Interest Rate 0.00%
Third tranche [Member] | Granted 2022 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 30.52%
Expected life of options (in years) 4
Equity Compensation Plan Risk Free Interest Rate (1.21%)
Third tranche [Member] | Granted 2023 [Member]  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Expected volatility 33.77%
Expected life of options (in years) 3.9
Equity Compensation Plan Risk Free Interest Rate 1.43%